AMRX - Amneal Pharmaceuticals, Inc.
13.02
-0.240 -1.843%
Share volume: 1,048,886
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$13.26
-0.24
-0.02%
View ratios
| Fiscal Date | 12-31-2025 | |
|---|---|---|
| Fiscal Quarter | Q4 2025 | |
| Report Date | 02-27-2026 | |
| Cash flow financing | -10.120 M | |
| Other financing cash flows | -3.996 M | |
| Cash flow | 74.741 M | |
| Net income | 49.573 M | |
| Depreciation | 49.227 M | |
| Changes in inventories | 0.000 | |
| Changes in receivables | 0.000 | |
| Investing Cashflow | -45.454 M | |
| Net Borrowings | 0.000 | |
| Investing Activity Other | 0.000 | |
| Dividends Paid | 0.000 | |
| Exchange Rate Effect | 0.000 | |
| Capital Expenditures | 42.454 M | |
| Cash Change | 74.532 M |